Skip to main content

Secondary Neoplasia

  • Chapter
  • First Online:
Pathology of the Pancreas

Abstract

The pancreas can be involved secondarily by extrapancreatic neoplasms, either by direct invasion or by metastatic spread along lymphatic channels, perineural clefts, or the blood stream. In principle, the possibility of a secondary neoplasm should always be considered as a differential when diagnosing a pancreatic cancer. This chapter focuses on the more common malignant neoplasms that metastasize to the pancreas, and provides detailed information on the differential diagnosis, including a table with useful immunohistochemical markers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Crippa S, Angelini C, Mussi C, Bonardi C, Romano F, Sartori P, et al. Surgical treatment of metastatic tumors to the pancreas: a single center experience and review of the literature. World J Surg. 2006;30:1536–42.

    Article  PubMed  Google Scholar 

  2. Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444:527–35.

    Article  PubMed  Google Scholar 

  3. Truong LD, Shen SS. Immunohistochemical diagnosis of renal neoplasms. Arch Pathol Lab Med. 2011;135:92–109.

    PubMed  Google Scholar 

  4. Park S-Y, Kim B-H, Kim J-H, Lee S, Kang GH. Panels of immunohistochemical markers help determine primary sites of metastatic adenocarcinoma. Arch Pathol Lab Med. 2007;131:1561–7.

    PubMed  CAS  Google Scholar 

  5. Dennis JL, Hvidsten TR, Wit EC, Komorowski J, Bell AK, Downie I, et al. Markers of adenocarcinoma characteristic of the site of origin: development of a diagnostic algorithm. Clin Cancer Res. 2005;11:3766–72.

    Article  PubMed  CAS  Google Scholar 

  6. Cai YC, Banner B, Glickman J, Odze RD. Cytokeratin 7 and 20 and thyroid transcription factor 1 can help distinguish pulmonary from gastrointestinal carcinoid and pancreatic endocrine tumors. Hum Pathol. 2001;32:1087–93.

    Article  PubMed  CAS  Google Scholar 

  7. Ordonez NG. Application of mesothelin immunostaining in tumor diagnosis. Am J Surg Pathol. 2003;27:1418–28.

    Article  PubMed  Google Scholar 

  8. Werling RW, Yaziji H, Bacchi CE, Gown AM. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin. An immunohistochemical survey of 476 primary and metastatic carcinomas. Am J Surg Pathol. 2003;27:303–10.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag London

About this chapter

Cite this chapter

Campbell, F., Verbeke, C.S. (2013). Secondary Neoplasia. In: Pathology of the Pancreas. Springer, London. https://doi.org/10.1007/978-1-4471-2449-8_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-2449-8_12

  • Published:

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-2448-1

  • Online ISBN: 978-1-4471-2449-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics